![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, May 04, 2017 11:43:29 AM
This is a very complex case for ViaDerma / Otiko and Keough, and truly even Philips unless he has a separate attorney who can get him out of the mix by stating he never sold it to Otiko. Either way though, IF ViaDerma can prove it has created an entirely new IP which is NOT based on Keough's IP (which doesn't seem to be the case) OR IF ViaDerma has a lot more money to play with, it can stand a decent chance of coming out on top. But if ViaDerma is banking on just the fact that the IP was abandoned, leadership is going to be in for a very unpleasant surprise.
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM